Search research articles
Contact Us
Filters
Showing results (141-150 of 220) with videos related to
Page
of 22
Sort By:
Human Pathology
|
May 23, 2008
Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer
S J Wilkinson, A Kucukmetin, P Cross, et al.
Journal of Medicinal Chemistry
|
April 1, 1986
Quinazoline antifolates inhibiting thymidylate synthase: benzoyl ring modifications
T R Jones, M J Smithers, M A Taylor, et al.
Seminars in Oncology
|
December 1, 1996
Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study
D Porter, A Boddy, H Thomas, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin
D R Newell, Z H Siddik, L A Gumbrell, et al.
The Journal of Organic Chemistry
|
July 7, 2023
Traceless Thioacid-Mediated Radical Cyclization of 1,6-Dienes
Dylan M Lynch, Mark D Nolan, Conor Williams, et al.
Seminars in Oncology
|
October 1, 1995
Carboplatin in combination with paclitaxel in advanced ovarian cancer: dose determination and pharmacokinetic and pharmacodynamic interactions
A H Calvert, A Boddy, N P Bailey, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1996
Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parameters
V Mummaneni, S Kaul, L N Igwemezie, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP)
R J Griffin, S Srinivasan, K Bowman, et al.
British Journal of Cancer
|
January 1, 1997
The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQ in human leukaemia and colorectal carcinoma cell lines
E J Estlin, K Balmanno, A H Calvert, et al.
British Journal of Cancer
|
February 1, 1993
Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277
B J Foster, D R Newell, J Carmichael, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 220) with videos related to
Sort By:
Page
of 22
Human Pathology
|
May 23, 2008
Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer
S J Wilkinson, A Kucukmetin, P Cross, et al.
Journal of Medicinal Chemistry
|
April 1, 1986
Quinazoline antifolates inhibiting thymidylate synthase: benzoyl ring modifications
T R Jones, M J Smithers, M A Taylor, et al.
Seminars in Oncology
|
December 1, 1996
Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study
D Porter, A Boddy, H Thomas, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin
D R Newell, Z H Siddik, L A Gumbrell, et al.
The Journal of Organic Chemistry
|
July 7, 2023
Traceless Thioacid-Mediated Radical Cyclization of 1,6-Dienes
Dylan M Lynch, Mark D Nolan, Conor Williams, et al.
Seminars in Oncology
|
October 1, 1995
Carboplatin in combination with paclitaxel in advanced ovarian cancer: dose determination and pharmacokinetic and pharmacodynamic interactions
A H Calvert, A Boddy, N P Bailey, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1996
Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parameters
V Mummaneni, S Kaul, L N Igwemezie, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP)
R J Griffin, S Srinivasan, K Bowman, et al.
British Journal of Cancer
|
January 1, 1997
The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQ in human leukaemia and colorectal carcinoma cell lines
E J Estlin, K Balmanno, A H Calvert, et al.
British Journal of Cancer
|
February 1, 1993
Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277
B J Foster, D R Newell, J Carmichael, et al.
Page
of 22